Roald Brouwer Acquires 4,000 Shares of Amrize (NYSE:AMRZ) Stock

Amrize Ltd (NYSE:AMRZ) CTO Roald Brouwer acquired 4,000 shares of Amrize stock in a transaction dated Friday, October 31st. The stock was bought at an average price of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the purchase, the chief technology officer owned 9,000 shares of the company’s stock, valued at approximately $465,930. This represents a 80.00% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Roald Brouwer also recently made the following trade(s):

• On Wednesday, August 27th, Roald Brouwer purchased 2,000 shares of Amrize stock. The shares were bought at an average price of $51.88 per share, for a total transaction of $103,760.00.

Amrize Stock Performance

Shares of AMRZ opened at $50.78 on Thursday. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $56.29. The stock has a market cap of $28.09 billion and a PE ratio of 65.10. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. The firm has a 50-day moving average of $50.56.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.03 by ($0.25). The company had revenue of $3.22 billion for the quarter.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. State of Wyoming purchased a new stake in Amrize in the third quarter valued at approximately $32,000. Global Retirement Partners LLC acquired a new position in shares of Amrize in the 3rd quarter valued at $48,000. Jones Financial Companies Lllp purchased a new stake in Amrize in the 3rd quarter valued at $53,000. BNP Paribas Financial Markets acquired a new stake in Amrize during the 2nd quarter worth $59,000. Finally, Groupe la Francaise purchased a new position in Amrize during the 2nd quarter worth $60,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on AMRZ shares. Barclays began coverage on shares of Amrize in a research report on Tuesday, October 7th. They set an “equal weight” rating for the company. Citigroup lifted their price target on Amrize from $60.00 to $63.00 and gave the stock a “buy” rating in a report on Monday. Zacks Research upgraded Amrize from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Royal Bank Of Canada cut their target price on Amrize from $61.00 to $54.00 and set an “outperform” rating on the stock in a research report on Friday, August 8th. Finally, Oppenheimer began coverage on Amrize in a research note on Tuesday, September 9th. They set an “outperform” rating and a $62.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $58.71.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.